BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 11399230)

  • 1. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
    Sin JI; Kim JJ; Zhang D; Weiner DB
    Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
    Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
    Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
    Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
    J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
    Sin J; Kim JJ; Pachuk C; Satishchandran C; Weiner DB
    J Virol; 2000 Dec; 74(23):11173-80. PubMed ID: 11070014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
    Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
    Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo.
    Sin JI; Kim J; Pachuk C; Weiner DB
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):751-8. PubMed ID: 10973449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.
    Sin JI; Kim JJ; Boyer JD; Ciccarelli RB; Higgins TJ; Weiner DB
    J Virol; 1999 Jan; 73(1):501-9. PubMed ID: 9847356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse.
    Tripp RA; Jones L; Anderson LJ; Brown MP
    J Immunol; 2000 Jun; 164(11):5913-21. PubMed ID: 10820273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
    Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
    J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
    Sin JI; Kim JJ; Ugen KE; Ciccarelli RB; Higgins TJ; Weiner DB
    Eur J Immunol; 1998 Nov; 28(11):3530-40. PubMed ID: 9842896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.
    Thebeau LG; Morrison LA
    J Virol; 2003 Feb; 77(4):2426-35. PubMed ID: 12551980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
    Sin JI; Bagarazzi M; Pachuk C; Weiner DB
    DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.
    Kim JJ; Nottingham LK; Sin JI; Tsai A; Morrison L; Oh J; Dang K; Hu Y; Kazahaya K; Bennett M; Dentchev T; Wilson DM; Chalian AA; Boyer JD; Agadjanyan MG; Weiner DB
    J Clin Invest; 1998 Sep; 102(6):1112-24. PubMed ID: 9739045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immune correlates can segregate by vaccine type in a murine herpes model system.
    Sin JI; Ayyavoo V; Boyer J; Kim J; Ciccarelli RB; Weiner DB
    Int Immunol; 1999 Nov; 11(11):1763-73. PubMed ID: 10545480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.
    Eo SK; Lee S; Chun S; Rouse BT
    J Virol; 2001 Jan; 75(2):569-78. PubMed ID: 11134269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant.
    Zhu M; Xu X; Liu H; Liu X; Wang S; Dong F; Yang B; Song G
    J Med Microbiol; 2003 Mar; 52(Pt 3):223-228. PubMed ID: 12621087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.